Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Current Assets (2016 - 2026)

Collegium Pharmaceutical has reported Current Assets over the past 11 years, most recently at $691.4 million for Q4 2025.

  • For Q4 2025, Current Assets rose 43.37% year-over-year to $691.4 million; the TTM value through Dec 2025 reached $691.4 million, up 43.37%, while the annual FY2025 figure was $691.4 million, 43.37% up from the prior year.
  • Current Assets for Q4 2025 was $691.4 million at Collegium Pharmaceutical, up from $613.9 million in the prior quarter.
  • Over five years, Current Assets peaked at $691.4 million in Q4 2025 and troughed at $296.3 million in Q1 2021.
  • A 5-year average of $468.0 million and a median of $490.3 million in 2023 define the central range for Current Assets.
  • Biggest five-year swings in Current Assets: dropped 17.37% in 2024 and later skyrocketed 43.37% in 2025.
  • Year by year, Current Assets stood at $315.5 million in 2021, then soared by 33.1% to $420.0 million in 2022, then rose by 28.0% to $537.6 million in 2023, then fell by 10.29% to $482.3 million in 2024, then soared by 43.37% to $691.4 million in 2025.
  • Business Quant data shows Current Assets for COLL at $691.4 million in Q4 2025, $613.9 million in Q3 2025, and $549.2 million in Q2 2025.